IPO Issue Details
Issue Price / Price Band₹111 per share (Fixed Price)
Face Value₹10 Per Share
Lot Size1,200 Shares per Lot
Total Issue Size30,00,000 shares (aggregating up to ₹33.30 Cr)
Issue TypeBookbuilding IPO
Sale Type / CategoryFresh Capital
Exchange / PlatformNSE SME
IPO TypeSME
Subscription OpenWed, 29 Mar 2023
Subscription CloseMon, 03 Apr 2023
Anchor AllotmentTue, 28 Mar 2023
Basis of AllotmentMon, 10 Apr 2023
Initiation of RefundsTue, 11 Apr 2023
Credit of Shares to DematWed, 12 Apr 2023
Listing DateThu, 13 Apr 2023
UPI Mandate Deadline2023-04-03
Application & Investment Details
Retail — Min (1 Lots)₹1,33,200 — 1,200 shares
Retail — Max (13 Lots)₹1,731,600 (13 Lots)
HNI — Min (2 Lots)₹2,66,400 — 2,400 shares
P/E Ratio (Pre-IPO)132.14x
Net Offer to Public28,50,000 shares (aggregating up to ₹31.64 Cr)
Reserved for Market Maker1,50,000 shares (aggregating up to ₹1.67 Cr)
Pre-IPO Promoter Holding80,50,000 shares
Post-IPO Promoter Holding1,10,50,000 shares
About Sotac Pharmaceuticals Ltd.
Incorporated in 2015, Sotac Pharmaceuticals Limited is a part of the SOTAC group, based in Gujarat. The company is in the business of manufacturing pharmaceutical products for different marketers on a loan license or contract manufacturing basis. The company's business is majorly on principle to principle basis with different marketers.SOTAC is serving over 162 corporate clients on a loan license and/or contract manufacturing basis. With their vast experience in the pharmaceutical segment, the company is growing and enlarging its scale of operations every year.Sotac Pharmaceuticals established its manufacturing facility in the year 2017. In the year, the company's manufacturing facility was installed with the capacity to manufacture 90 Crore tables/year, and 14 Crore Capsules/year.With a combined experience of over 59 years in the pharmaceutical manufacturing Industry of the Promoters, the company is blooming and expanding in various horizons.
Objects of the Issue
Sotac Pharmaceuticals Ltd. proposes to utilise the net proceeds from the Issue for the following objects:
1
To Meet Working Capital Requirements
10.80
2
Investment in Subsidiary
7.00
3
Upgradation / Construction of Existing /New Building in the Existing Premises
5.90
4
General Corporate Purpose
7.40
Shareholding & Lock-in
Pre-IPO Promoter Holding
80,50,000 shares
Post-IPO Promoter Holding
1,10,50,000 shares